Pharming Group N.V. (PHAR)
Recent Filing Index
Filing Summary
| Report Name | Notes | Fiscal Period (Annual) | Fiscal Period (Quarter) |
|---|---|---|
| Cover | — |
|
| Audit Information | — |
|
| Statements | ||
| Consolidated Statement of Income | — |
|
| Consolidated Statement of Comprehensive Income | — |
|
| Consolidated Balance Sheet | — |
|
| Consolidated Statement of Changes In Equity | — |
|
| Consolidated Statement of Cash Flows | — |
|
| Notes | ||
| Accounting Principles and Policies | — |
|
| Board of Directors | — |
|
| Business Combinations and Acquisitions of Non-controlling Interests | — |
|
| Commitments and Contingencies | — |
|
| Convertible Bonds | — |
|
| Corporate Information | — |
|
| Cybersecurity Risk Management and Strategy Disclosure | — |
|
| Earnings Per Share and Fully-diluted Shares | — |
|
| Events After The Reporting Year | — |
|
| Expenses By Nature | — |
|
| Financial Risk Management | — |
|
| Income Tax | — |
|
| Insider Trading Policies and Procedures | — |
|
| Intangible Assets | — |
|
| Inventories | — |
|
| Investments | — |
|
| Leases | — |
|
| Marketable Securities | — |
|
| Other Finance Income and Expenses | — |
|
| Other Financial Income and Expenses | — |
|
| Other Income | — |
|
| Property, Plant and Equipment | — |
|
| Provisions | — |
|
| Related Party Transactions | — |
|
| Restricted Cash, Cash and Cash Equivalents | — |
|
| Revenue | — |
|
| Right-of-use Assets | — |
|
| Segment Information | — |
|
| Share-based Compensation | — |
|
| Shareholders' Equity | — |
|
| Trade and Other Payable | — |
|
| Trade and Other Receivables | — |
|